Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Corvus Pharma Com (NQ: CRVS )

4.050 USD +0.160 (+4.11%)
Official Closing Price Updated: 5:24 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 257,000
Open 3.890
Bid (Size) 3.900 (1)
Ask (Size) 4.050 (2)
Prev. Close 3.890
Today's Range 3.810 - 4.090
52wk Range 1.010 - 6.880
Shares Outstanding 29,193,600
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition
From GlobeNewswire News Releases
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
Includes updated data from CPI-818 phase 1/1b trial and pre-clinical results supporting use in autoimmune lymphoproliferative syndrome (ALPS) 
From GlobeNewswire News Releases

Performance

YTD
+7.14%
+7.14%
1 Month
+2.53%
+2.53%
3 Month
+2.27%
+2.27%
6 Month
-5.59%
-5.59%
1 Year
-31.70%
-31.70%

More News

Read More
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
From GlobeNewswire News Releases
Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From GlobeNewswire News Releases
Are These The Best Penny Stocks To Buy Now? 5 Biotech Stocks To Know
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Corvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Session at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From GlobeNewswire News Releases
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Corvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for Patients with COVID-19 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From GlobeNewswire News Releases
10 Biggest Price Target Changes For Tuesday
Tags Benzinga CRVS TSE
From Benzinga
Week in Review: $1.5 Billion Total in Week's China Deals
From ChinaBio® Today
Mid-Afternoon Market Update: Dow Surges 350 Points; Eidos Therapeutics Shares Spike Higher
Tags CRVS PEIX Global
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.